http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0278416-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10
filingDate 1988-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1992-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1992-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0278416-B1
titleOfInvention Use of human blood coagulation factor xiii for the treatment of ulcerative colitis
abstract The use of human blood coagulation factor XIII for the treatment of ulcerative colitis is demonstrated in 4 representative cases. Treatment with factor XIII leads to rapid and total disappearance of the chief symptoms realizing transition to the remission stage.
priorityDate 1987-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128812924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396692
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226552901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20055127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128681276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128691975

Total number of triples: 38.